You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JNJ-54767414

Showing 26 - 50 of 458
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Japan (Daratumumab (16 mg/kg), Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Daratumumab (16 mg/kg)
  • +2 more
  • Hiroshima, Japan
  • +4 more
Apr 2, 2020

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Newly Diagnosed Primary Amyloidosis, Recurrent Primary Amyloidosis, Refractory Primary Amyloidosis Trial in Houston

Recruiting
  • Newly Diagnosed Primary Amyloidosis
  • +2 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 12, 2021

Healthy Trial in Tempe (Daratumumab, Placebo, rHuPH20)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Sep 4, 2019

Amyloidosis Trial in Worldwide (Daratumumab, Cyclophosphamide, Bortezomib)

Recruiting
  • Amyloidosis
  • Duarte, California
  • +46 more
Aug 5, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Indianapolis, Rochester, Wauwatosa (Bortezomib,

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Indianapolis, Indiana
  • +2 more
Sep 29, 2020

Plasma Cell Myeloma Trial in Columbus (Daratumumab)

Completed
Has Results
  • Plasma Cell Myeloma
  • Daratumumab
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 14, 2019

Multiple Myeloma Trial in Japan (JNJ-54767414 (Daratumumab), Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • JNJ-54767414 (Daratumumab)
  • +2 more
  • Hiroshima, Japan
  • +4 more
Mar 5, 2019

Multiple Myeloma Trial in Germany, Greece (Daratumumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Berlin, Germany
  • +9 more
May 27, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +113 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

NSCLC Trial in Worldwide (Atezolizumab, Daratumumab)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Loma Linda, California
  • +46 more
Nov 5, 2019

Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
Jan 17, 2023

Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

Not yet recruiting
  • Advanced Prostate Cancer
  • Lyon, France
  • +2 more
Oct 18, 2023

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • (no location specified)
Nov 15, 2023

Healthy Trial in Lincoln (JNJ-68179280, Placebo)

Recruiting
  • Healthy
  • Lincoln, Nebraska
    Celerion
Jan 17, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

Active, not recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Los Angeles, California
  • +6 more
Jan 18, 2023

Metastatic Castration-resistant Prostate Tumors Trial in Australia, Korea, Republic of, United States (JNJ-78278343, Cetrelimab)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Neoplasms
  • Sarasota, Florida
  • +7 more
Apr 6, 2023

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Healthy Trial in Leiden (JNJ-69095897, Placebo)

Recruiting
  • Healthy
  • Leiden, Netherlands
    Centre for Human Drug Research
Jan 31, 2023

Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

Recruiting
  • Plaque Psoriasis
  • Rolling Meadows, Illinois
  • +8 more
Oct 18, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (JNJ-79635322)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Edegem, Belgium
  • +16 more
Jan 27, 2023

Multiple Myeloma Trial in Japan, United States (JNJ-68284528)

Completed
  • Multiple Myeloma
  • JNJ-68284528
  • Phoenix, Arizona
  • +20 more
Oct 5, 2022

Healthy Trial in Merksem (JNJ-67835989, Placebo)

Completed
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jul 20, 2022